Background
==========

*Candida*infections are a growing concern in patients hospitalized in intensive care units (ICUs) \[[@B1]\]. Among the yeasts involved, *C. albicans*is still predominant in ICUs, accounting for 55% of yeast bloodstream infections \[[@B2],[@B3]\]. Most of these infections are nosocomial, which raises the issue of their prevention. Understanding the route of contamination is of utmost importance in order to implement adequate preventive guidelines.

Genotyping is an approach that can be used to detect cross-contamination. Several genotyping techniques have been reported \[[@B4]\]. Among them, polymorphic microsatellite markers (PMM) have a high discriminatory power and a high throughput when fluorogenic primers and an automated sequencer are used for analysis\[[@B5],[@B6]\]. The data are computerizable and can be compared.

In a previous study on an ICU \[[@B7]\], we used genotyping to show that cross-contamination with *C. albicans*was unlikely and that most of the patients were colonized with their own strain. The aim of the present study was to determine whether this finding was specific or could be generalized to another ICU in another hospital. Moreover, if a nosocomial acquisition occurs in a given hospital, a *C. albicans*population specific to that hospital is expected. Therefore, we studied the genotypes of *C. albicans*isolates of a different ICU from a new hospital and compared the results with those previously reported to detect potential hospital-specific populations. The genotyping was performed using three PMM known to have a discriminatory power of 0.97 \[[@B5]\].

Methods
=======

Study populations
-----------------

The study was conducted in the ICU of Versailles hospital, referred to as Hospital A, located southwest of Paris, and the results were compared to those obtained in Henri Mondor hospital, referred to as Hospital B, located southeast of Paris, forty kilometres from Hospital A.

The ICU of Hospital A (18-bed ward) treats both medical and surgical patients whereas the ICU of Hospital B (16-bed ward) has only surgical patients. Patients above 18 years of age and at high risk for *Candida*infection were eligible for the study. The criteria for inclusion were recent abdominal surgery (\<24 hours), gastrointestinal perforation or anastomotic leakages, urologic tract surgery and/or broad-spectrum therapy for more than eight days \[[@B7]\]. The following information was recorded for each patient: age, sex, new Simplified Acute Physiology Score (SAPS II) \[[@B8]\], presence of diabetes, immunodepression, wide-spectrum antibiotic therapy, orally administered amphotericin B, presence of arterial or central venous catheter, transfusion requirement, total parenteral nutrition, type of surgery and length of ICU stay. The Comité Consultatif de Protection des Personnes dans la Recherche Biomédicale of each hospital confirmed that no ethical approval was required since this observational study did not modify current diagnostic or therapeutic strategies. Written or oral informed consent was obtained from patients or from their relatives.

Sampling
--------

In both hospitals, patients were sampled for colonization at entry in the ICU and then once weekly. The sampling consisted of skin and mouth swabs, urine, stools and tracheal aspirations. Clinical specimens were cultured on chromogenic medium for 48 hours at 37°C. All green colonies (CHROMagar^®^*Candida*for Hospital A) and blue colonies (*Candida*ID^®^, BioMérieux for Hospital B were identified as *C. albicans*. The others colonies were identified using commercially available strips (Api 20C^®^, BioMérieux in Hospital A or ATB ID32C^®^, BioMérieux in Hospital B) together with micromorphological analysis on rice-extract agar (Becton Dickinson). One colony per sample was put into 1 ml of 10% glycerol and frozen at -80°C until PCR analysis.

Microsatellite analysis
-----------------------

The surface of the *C. albicans*frozen aliquots was scraped with a loop and the material obtained was seeded on Sabouraud medium. After 24 h, one colony was directly suspended in 100 μl of sterile water and boiled to free DNA. After centrifugation for 3 minutes at 2000 × g, 2 μl of the supernatant was used to amplify three polymorphic loci named \"CDC3\", \"EF3\" and \"HIS3\" after the genes they are located closest to. Primers were designed to amplify the microsatellite markers and one primer of each set was 5\'-labeled with different dyes as previously described \[[@B5]\]. In Hospital A, the PCR products were run in capillary and read using a 310 automated sequencer (Applied Biosystems). The data were stored and analyzed using the 372 GeneScan software (Applied Biosystems).

The 372 GeneScan software automatically calculates the PCR fragment length according to the internal standard and gives fractional numbers. To check the reproducibility of the technique, we tested the B311 reference strain in ten separate experiments. This strain is heterozygous for the three markers and the length in base pairs (bp) of each allele is known \[[@B5]\]. The standard deviation was +/- 0.20 bp for CDC3, +/- 0.24 for EF3, and +/- 0.42 for HIS3. To assign a specific length to a PCR fragment, we systematically tested the B311 strain in all the PCR runs. All the PCR results were aligned with this reference strain. Therefore, each allele was named according to the length in bp of the amplified fragment after the alignment with the reference strain. When several isolates were available for a given patient, all the profiles were also aligned to check their similarity. When we observed electromorphs with one signal for a given locus, we considered that the isolates were homozygous for this locus \[[@B9]\].

Comparaison of PMM analysis between the two hospitals
-----------------------------------------------------

In Hospital A, the PCR products were run in capillary and read using a 370 automated sequencer (Applied Biosystems). For Hospital B \[[@B7]\], we ran the PCR products on a 36-cm long acrylamide urea gel and read the signals using a 377 automated sequencer (Applied Biosystems). After analysis by the 372 GeneScan software (Applied Biosystems), we were obliged to make some corrections because of the different automated sequencers used in each place. The differences observed between the 377 -- 310 sequencers for 6 reference strains (Ca 4918, IP1877/89, IP996/69, IP1880/89, H12, B311) were 0.4 nucleotide for CDC3, 2.4 nucleotides for EF3 and one nucleotide for HIS3. Therefore, using the B311 strain ran in each series, we calculated the differences between the length obtained with the 310 sequencer and that calculated with the 377 sequencer and reported in previous publications \[[@B5]\]. We added to each allele of each locus the difference calculated to obtain comparative results. As described above, each profile was compared with the B311 strain profile and the length in base pairs was given according to the known length of the B311 alleles.

Statistical analysis
--------------------

Two kinds of statistical analysis were used to compare Hospital A and B\'s populations: the genotypic differentiation test called the G test and a multiple correspondence analysis (MCA). The G test analyzes the diversity of diploid populations on multi-loci where multi-allelic possibilities exist and tests the null hypothesis that the distribution is identical across populations \[[@B10]\]. A likelihood test of the observations is performed and the result is given by a probability *P*based on a Fischer\'s test. If *P*\> 0.05, the compared populations are considered as similar. This test is suitable for molecular markers such as PMM in diploid populations, with a high level of genetic diversity, when the loci can be considered independent \[[@B11]\]. The data were coded and analyzed using the GenePop software version 3.4 June 2003 \[[@B12]\].

A cluster analysis between the two populations was performed by MCA which is an ordination technique. MCA is a type of Correspondence Analysis (CA) which considerably expands the scope of Principal Components Analysis (PCA). The percentage *inertia*explained by axes takes the place of the percentage variance of PCA. PMM data can be coded by 1 (presence) or 0 (absence) for each of the possible allele. Such coding leads to complete disjunctive data used in the MCA. One byproduct is that the row and column projections in the new space may both be plotted on the same output graphic presentations. For our analysis, only the six first axes were considered for explaining the contingency table variability. Scatter plots were chosen for a graphic representation. They were centered in the first two axes. This analysis was performed using the XLSTAT (version 7.5) software package \[[@B13]\]. A hierarchical classification by a neighbor-joining with the squared Euclidian distances was determined from the six first axes of the MCA.

Results
=======

In Hospital A, 1424 patients were hospitalized from 1^st^February 2000 to 31^st^January 2002, and 60 patients were included. Among them, 56 patients (93%) had at least one sample that was positive for *Candida*sp. For 11 of them, the culture was positive as early as the first day of hospitalization in the ICU. The 45 other patients had positive samples after a minimum of 72 hours. In Hospital B, 303 patients were hospitalized from 1^st^November 1999 to 31^st^October 2000, and 94 patients were included. Among them, 43 patients (46%) had at least one positive sample in culture and 36 had positive samples after a minimum of 72 hours. Table [1](#T1){ref-type="table"} lists the demographic data and the main characteristics of the patients in the two hospitals who acquired any *Candida*sp colonization after 72 hours of hospitalization. The percentage of acquisition after 72 h was 80.3% (45/56) in Hospital A and 83.7% (36/43) in Hospital B. The number of positive cultures for *Candida*spp. was 156 out of 333 (47%) specimens recovered in Hospital A. The figure was lower in Hospital B where 167 out of the 1126 (15%) samples were culture positive. Despite this finding, there was no significant difference in the distribution of *Candida*species (data not shown).

###### 

Main characteristics of the patients who acquired any *Candida*sp colonization after 72 hours of hospitalization in Hospital A (45/56, i;e. 80.3%) and in Hospital B (36/43, i.e; 83.7%).

  Patient characteristics                               Hospital A n = 45 (%)   Hospital B n = 36 (%)   *P*
  ----------------------------------------------------- ----------------------- ----------------------- ---------
  Age (years) mean ± SD                                 66.4 ± 15.4             62.6 ± 16.4             0.57
  Sex ratio (M/F)                                       25/20                   23/13                   0.42
  SAPS II score: mean points ± SD                       45.5 ± 14               37.5 ± 14.5             0.19
  Diabetes                                              4 (8.9)                 6 (16.7)                0.28
  Immunodepression                                      17 (37.8)               9 (25.0)                0.26
  Previous administration of antibiotics                43 (95.6)               26 (72.2)               0.25
  Oral amphotericin B                                   0                       32 (88.9)               0.001\*
  Central venous catheter                               37 (82.2)               34 (94.4)               0.40
  Radial artery catheter                                21 (46.7)               31 (86.1)               0.06
  Transfusion requirements                              17 (37.8)               29 (80.6)               0.03\*
  Total parenteral nutrition                            15 (33.3)               27 (75.0)               0.03\*
  Abdominal surgery                                     11 (24.4)               21 (57.9)               0.03\*
  Liver transplant                                      0                       3 (8.3)                 0.10
  Length of stay: median days (25th-75th percentiles)   21 (11--53)             31 (14.0--55.5)         0.07

\*: statistically significant difference. *P*calculated by a Fisher\'s exact test.

In Hospital A, 82 isolates from different anatomical sites (Table [2](#T2){ref-type="table"}) were genotyped from the 36 patients with at least one positive culture for *C. albicans*. The genotype was identical for a given patient whatever the anatomical site. Only one patient sequentially harboured two different genotypes in the same anatomical site (see below). In Hospital B, 122 *C. albicans*isolates from different anatomical sites (Table [2](#T2){ref-type="table"}) from 30 patients had been genotyped \[[@B5]\].

###### 

Source of the 82 *C. albicans*genotyped isolates from 36 patients in Hospital A and the 122 *C albicans*genotyped isolates from 30 patients in Hospital B.

                                                       No (%) of positive specimens                                 
  ---------------------------------------------------- ------------------------------ ------------ -------- ------- ---------
  Clinical sample                                      Hospital A                     Hospital B   *P*              
                                                                                                                    
                                                       Number                         \%           Number   \%      
                                                                                                                    
  Mouth, skin and superficial surgical wounds          38                             46.3         1        0.8     0.001\*
  Peritoneal fluid, abscess, drain effluent and bile   3                              3.6          50       41      0.001\*
  Stools and gastric secretions                        15                             18.3         18       14.7    0.350
  Urinary tract                                        11                             13.4         15       12.3    0.498
  Respiratory tract                                    15                             18.3         34       27.8    0.141
  Blood                                                0                              0.0          2        1.6     0.361
  Central venous catheter                              0                              0.0          2        1.6     0.361
  Total                                                82                             100.0        122      100.0   

\* *P*\< 0.05: significant differences. (*P*calculated by a Fisher\'s exact test).

In Hospital A, 36 patients had at least one positive culture of *C. albicans*and 19 patients had serial *C. albicans*isolates. Of these 19 patients, only one patient had two different genotypes of *C. albicans*. The first genotype was specific for the patient while the second genotype, obtained 8 days later, was a genotype found in other patients. Nevertheless, we kept both genotypes of this patient for further analysis. Among these 36 patients, 26 (72%) had a specific genotype, 8 (22%) shared the multilocus genotype characterized by CDC3: 117--125; EF3: 126--135; HIS3: 162-162 whose the frequency is 17% among 100 unrelated isolates \[[@B5]\], and two other patients (6%) shared another identical genotype (CDC3: 117--125; EF3: 130--131; HIS3: 162-162). None of the 8 patients sharing the most common multilocus genotype stayed in the ICU over the same period of time, the time interval between the dates of hospitalization in the ICU ranging from 28 to 78 days. The stay of the other 2 patients differed by an interval of 13 days. In Hospital B, the most common multilocus genotype had been found in three (10%) out of 30 patients whose stay in the ICU differed by 7 to 96 days.

Therefore, 37 genotypes from 36 different patients in Hospital A and 30 genotypes from 30 different patients in Hospital B were available for comparison. The allelic frequencies were not statistically different for 34 of the 38 different alleles observed. Table [3](#T3){ref-type="table"} reports the multilocus genotypes of the *C. albicans*isolates observed in the two hospitals. With the genotypic differentiation, the pairwise analysis across the two populations suggested that the populations were not significantly different (*P*\> 0.05) for the three PMM: CDC3 (*P*= 0.12), EF3 (*P*= 0.25) and HIS3 (*P*= 0.12).

###### 

Multilocus genotypes of the *C. albicans*isolates of the two hospitals studied.

  CDC3 locus   EF3 locus   HIS3 locus   number of isolates                                              
  ------------ ----------- ------------ -------------------- ---------- ---------- -------------------- ---------------------
  Allele 1     Allele 2    Allele 1     Allele 2             Allele 1   Allele 2   Hospital A (n= 37)   Hospital B (n = 30)
                                                                                                        
  113          117         130          136                  150        162        0                    3
  113          117         130          136                  162        162        1                    1
  113          117         136          136                  150        162        1                    0
  113          117         136          136                  162        162        1                    0
  113          117         136          142                  158        158        1                    0
  117          117         126          135                  162        162        0                    1
  117          117         130          136                  150        162        0                    1
  117          117         130          136                  154        194        0                    1
  117          117         133          140                  154        154        0                    1
  117          117         133          144                  154        178        0                    1
  117          117         133          144                  154        186        0                    1
  117          117         136          136                  162        162        1                    0
  117          117         136          144                  154        154        1                    0
  117          117         137          139                  182        182        0                    1
  117          121         131          130                  162        186        1                    0
  117          121         132          135                  154        162        1                    0
  117          121         133          136                  154        154        0                    1
  117          121         136          139                  154        154        1                    0
  117          125         126          126                  162        162        1                    0
  117          125         126          126                  162        162        0                    1
  117          125         126          135                  154        162        1                    0
  117          125         126          135                  154        166        1                    0
  117          125         126          135                  158        158        1                    0
  117          125         126          135                  162        162        8                    3
  117          125         126          135                  170        218        0                    1
  117          125         126          135                  202        210        1                    0
  117          125         126          135                  210        218        0                    1
  117          125         126          135                  218        230        1                    0
  117          125         130          130                  162        162        1                    1
  117          125         130          144                  154        154        0                    1
  117          125         131          130                  162        162        2                    0
  117          125         131          131                  162        162        0                    1
  117          125         131          131                  162        190        0                    1
  117          125         131          131                  166        166        0                    2
  117          125         133          144                  154        182        0                    1
  117          125         136          139                  154        154        1                    0
  117          129         136          146                  154        154        0                    1
  121          121         136          136                  154        154        1                    0
  121          125         130          144                  154        154        1                    0
  121          125         130          144                  154        166        1                    0
  121          125         144          144                  174        174        1                    0
  121          125         145          150                  166        174        1                    0
  125          125         126          135                  162        162        1                    0
  125          125         130          144                  154        154        1                    0
  125          125         130          144                  154        166        1                    0
  125          125         130          145                  154        166        0                    1
  125          125         131          139                  194        198        0                    1
  125          125         136          139                  150        150        1                    0
  125          129         130          144                  154        154        1                    0
  129          129         136          141                  150        162        0                    2

The isolates were also analyzed by MCA according to their multilocus genotype. MCA produced a multidimensional representation of the data, which were reduced in plane for convenience. The two first factor axes corresponding to the percentage of the total inertia of 7.56% and 7.29% respectively are shown on Figure [1](#F1){ref-type="fig"}. Both populations of Hospital A and B are superimposable on this representation without presenting clusters, except for two particular Hospital A multilocus genotypes (A31 and A32 on figure [1B](#F1){ref-type="fig"}). We determined that only the six first axes (a range of inertia from about 7.6 to 5.1%) present at least one significant correlation (t-test) with the initial variables. To confirm that the two populations were superimposed in all axes, we performed a hierarchical classification by a neighbor-joining with the squared Euclidian distances determined from the six first axes of the MCA. The corresponding unrooted tree is shown on Figure [2](#F2){ref-type="fig"}. We observed that independently of the origin of the multilocus genotypes, both populations were distributed in all branches of the tree without discriminate some clusters. No association of a genotype with a particular Hospital could be detected.

![Multiple correspondences analysis for the 37 Hospital A multilocus genotypes and the 30 Hospital B multilocus genotypes. The projection in the plane defined by the two most informative axes is shown (axis 1 variance: 7.56%; axis 2 variance: 7.29%). Although different, some multilocus genotypes are superimposble because of the projection on the plane. Green spots: Hospital A genotypes; blue spots: Hospital B genotypes; red spots: commun genotypes between the two hospitals.](1471-2334-6-162-1){#F1}

![Unrooted tree obtained after hierarchical classification by a neighbor-joining with the squared Euclidian distances determined from the six first axes of the multiple correspondence analysis. Same colour code as in Figure 2. Multilocus genotypes numbers are arbitrary.](1471-2334-6-162-2){#F2}

Discussion
==========

The aim of the present study was to compare the genotypes of *C. albicans*in two ICUs of two different hospitals to determine whether or not cross-contamination occurs. In Hospital B, a previous study had concluded that there was a low probability of cross contamination between patients \[[@B7]\]. This was confirmed in the present study in Hospital A. Among 36 patients, 26 had a specific *C. albicans*multilocus genotype and, once colonized, the patient usually kept the same genotypes whatever the anatomical site. However, eight patients shared a multilocus genotype which is the most common multilocus genotype among independent isolates \[[@B5]\]. The probability of cross-contamination was low given that they were not hospitalized at the same time in the ICU. Fomites might have had a reservoir role. However, in ICUs, the cleaning procedures between patients exclude this possibility. We cannot rule out that a medical staff member might have served as a common contaminator. However, the most common shared multilocus genotype also belongs to the most common genotype in the general population, which accounted for 17% of 100 unrelated *C albicans*isolates \[[@B5]\]. The fact that some genotypes are more frequent than others has already been reported for *C. albicans*by other authors using PMM \[[@B6],[@B14]-[@B16]\]. This may be due to the 0.97 discriminatory power of the present PMM and can be solved by using other PMM \[[@B6]\] to increase the discriminatory power or by using another typing method such as MLST \[[@B17]\]. This may also be due to the lack of a sexual cycle in *C. albicans*and the expansion of some clones \[[@B18]\].

Similarities were found regarding the epidemiology of *C. albicans*, i.e. that most fungal infections that arise in an ICU are caused by unrelated strains, although there were differences between the two hospitals which could have led to less similarities. For instance, the ICU of Hospital A treats medical and surgical patients. In contrast, Hospital B recruits only surgical patients, deemed to be more susceptible to infections since they are more immunocompromised (liver transplant, pancreatitis) or have undergone more invasive procedures. What was in fact surprising was the vast difference in the percentage of positive culture between both hospitals, 47% (156/333) in Hospital A versus 15% (167/1126) in Hospital B. The role of the different media used for fungal growth seems unlikely. An explanation could be could be the role of amphotericin B prophylaxis, implemented in Hospital B only, which could have hampered yeast growth. Other studies have reported similar differences in yeast colonization between 50% \[[@B1]\] and 90% \[[@B19]\]. This underlines the difficulties in standardizing clinical specimens and the microbiological procedures. However, despite these differences, the percentage of patients exhibiting a *C. albicans*colonization after 72 h was similar between the two hospitals (Table [1](#T1){ref-type="table"}) and the species distribution was also similar.

The second point of our study was to determine whether there was a *C. albicans*population specific to a given hospital, which might have suggested a nosocomial transmission or a difference in the patient population hospitalized. The G test and the MCA of PMM genotypes concluded with the absence of a *C. albicans*population specific to a given hospital (Figure [1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). Using the moderately repetitive sequence Ca3 to fingerprint *C. albicans*isolates in two distant hospitals in New Zealand \[[@B20]\], the authors have provided indirect evidence of nosocomial transmission of hospital-specific *C. albicans*strains in one hospital but not the other. Interestingly, these results were obtained under conditions in which no candidiasis outbreak occurred in either hospital, as was the case in our study. Therefore, more systematic screening to investigate *C. albicans*populations in ICUs might suggest intra-hospital acquisition and lead to reinforcement of clinical procedures. Of course, when an outbreak occurs, the genotyping of the *C. albicans*isolates can demonstrate the exogenous acquisition and should lead to preventive measures \[[@B21]\].

The PMM analysis produces computerizable data. However, technical issues should be pointed out since different migration techniques (acrylamide gel versus capillary) and not genome instability led to different allele sizes from the same genotype. The lengths of the PCR fragments and their secondary structures probably interfered with the migration \[[@B22]\]. This should be taken into consideration when comparing results between different laboratories, especially when the lengths of the PCR fragments differ in only one or two bases. Nevertheless, this shortcoming does not change the multilocus genotypes and the discriminatory power does not depend on the migration technique used. Agreement between laboratories should be achieved by using reference strains with known allelic lengths. Despite very few limitations, the PMM technique is well-designed for screening large number of isolates with limited workload. The same technique can be advantageously designed for the study of other yeasts, especially *C. glabrata*\[[@B23]\] which is the second leading species encountered in ICUs.

Conclusion
==========

The present study reinforces previous statements obtained from a single hospital supporting the fact that patients harbour their own *C. albicans*isolate \[[@B7],[@B24]\]. We also found that there was no genotype specific to any given hospital, thus reinforcing the hypothesis that nosocomial transmission exceptionally occurs in patients hospitalized in the ICU. Therefore, attempts aimed at preventing *C. albicans*colonization should focus on controlling the risk factors rather than on limiting cross-contamination as this yeast rarely appears responsible for cross-contamination between patients in the same ward.
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